Skip to main content
Log in

Berberine Ameliorate Oxidative Stress and Astrogliosis in the Hippocampus of STZ-Induced Diabetic Rats

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Diabetes mellitus increases the risk of central nervous system (CNS) disorders such as stroke, seizures, dementia, and cognitive impairment. Berberine, a natural isoquinoline alkaloid, is reported to exhibit beneficial effect in various neurodegenerative and neuropsychiatric disorders. Moreover, astrocytes are proving critical for normal CNS function, and alterations in their activity and impaired oxidative stress could contribute to diabetes-related cognitive dysfunction. Metabolic and oxidative insults often cause rapid changes in glial cells. Key indicators of this response are increased synthesis of glial fibrillary acidic protein (GFAP) as an astrocytic marker. Therefore, we examined the effects of berberine on glial reactivity of hippocampus in streptozotocin (STZ)-induced diabetic rats, using GFAP immunohistochemistry. Lipid peroxidation, superoxide dismutase (SOD) activity, and nitrite levels were assessed as the parameters of oxidative stress. Eight weeks after diabetes induction, we observed increased numbers of GFAP+ astrocytes immunostaining associated with increased lipid peroxidation, decreased superoxide dismutase activity, and elevated nitrite levels in the hippocampus of STZ-diabetic rats. In contrast, chronic treatment with berberine (50 and 100 mg/kg p.o. once daily) lowered hyperglycemia, reduced oxidative stress, and prevented the upregulation of GFAP in the brain of diabetic rats. In conclusion, the present study demonstrated that the treatment with berberine resulted in an obvious reduction of oxidative stress and GFAP-immunoreactive astrocytes in the hippocampus of STZ-induced diabetic rats.

Berberine and Gliosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Northam EA et al (2009) Central nervous system function in youth with type 1 diabetes 12 years after disease onset. Diabetes Care 32:445–450. doi:10.2337/Dc08-1657

    Article  PubMed Central  PubMed  Google Scholar 

  2. Rains JL, Jain SK (2011) Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50:567–575. doi:10.1016/j.freeradbiomed.2010.12.006

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Russell JW et al (2008) Oxidative injury and neuropathy in diabetes and impaired glucose tolerance. Neurobiol Dis 30:420–429. doi:10.1016/j.nbd.2008.02.013

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Pitocco D et al (2010) Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud: RDS 7:15–25. doi:10.1900/RDS.2010.7.15

    Article  PubMed Central  PubMed  Google Scholar 

  5. Pekny M, Pekna M (2004) Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204:428–437. doi:10.1002/path.1645

    Article  CAS  PubMed  Google Scholar 

  6. Rolo AP, Palmeira CM (2006) Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167–178. doi:10.1016/j.taap.2006.01.003

    Article  CAS  PubMed  Google Scholar 

  7. Hamby ME, Sofroniew MV (2010) Reactive astrocytes as therapeutic targets for CNS disorders. Neurotherapeutics 7:494–506. doi:10.1016/j.nurt.2010.07.003

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Kimelberg HK, Nedergaard M (2010) Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 7:338–353. doi:10.1016/j.nurt.2010.07.006

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Baydas G et al (2003) Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radic Biol Med 35:797–804. doi:10.1016/S0891-5849(03)00408-8

    Article  CAS  PubMed  Google Scholar 

  10. Pekny M, Wilhelmsson U, Bogestål YR, Pekna M (2007) In: Tiziana Corasaniti Giacinto Bagetta M, Lipton Stuart A (eds) International review of neurobiology, vol. 82. Academic, New York, pp 95–111

    Google Scholar 

  11. Middeldorp J, Hol EM (2011) GFAP in health and disease. Prog Neurobiol 93:421–443. doi:10.1016/j.pneurobio.2011.01.005

    Article  CAS  PubMed  Google Scholar 

  12. Coleman E, Judd R, Hoe L, Dennis J, Posner P (2004) Effects of diabetes mellitus on astrocyte GFAP and glutamate transporters in the CNS. Glia 48:166–178. doi:10.1002/glia.20068

    Article  PubMed  Google Scholar 

  13. Imanshahidi M, Hosseinzadeh H (2008) Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 22:999–1012. doi:10.1002/ptr.2399

    Article  CAS  PubMed  Google Scholar 

  14. Kulkarni SK, Dhir A (2008) On the mechanism of antidepressant-like action of berberine chloride. Eur J Pharmacol 589:163–172. doi:10.1016/j.ejphar.2008.05.043

    Article  CAS  PubMed  Google Scholar 

  15. Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res 24:317–324. doi:10.1002/Ptr.2968

    Article  CAS  PubMed  Google Scholar 

  16. Bhutada P et al (2011) Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res 220:30–41. doi:10.1016/j.bbr.2011.01.022

    Article  CAS  PubMed  Google Scholar 

  17. Cok A et al (2011) Berberine acutely activates the glucose transport activity of GLUT1. Biochimie 93:1187–1192. doi:10.1016/j.biochi.2011.04.013

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Gu Y et al (2010) Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. Talanta 81:766–772. doi:10.1016/j.talanta.2010.01.015

    Article  CAS  PubMed  Google Scholar 

  19. Lee YS et al (2006) Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55:2256–2264. doi:10.2337/Db06-0006

    Article  CAS  PubMed  Google Scholar 

  20. Zhou JY et al (2009) Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol 606:262–268. doi:10.1016/j.ejphar.2008.12.056

    Article  CAS  PubMed  Google Scholar 

  21. Kong WJ et al (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58:109–119. doi:10.1016/j.metabol.2008.08.013

    Article  CAS  PubMed  Google Scholar 

  22. Huang L, Shi AD, He F, Li XS (2010) Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors. Bioorgan Med Chem 18:1244–1251. doi:10.1016/j.bmc.2009.12.035

    Article  CAS  Google Scholar 

  23. Peng WH, Hsieh MT, Wu CR (1997) Effect of long-term administration of berberine on scopolamine-induced amnesia in rats. Jpn J Pharmacol 74:261–266

    Article  CAS  PubMed  Google Scholar 

  24. Zhu, F. Q., Qian, C. Y. (2006) Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci 7, doi:10.1186/1471-2202-7-78

  25. Yoo JH et al (2006) Inhibitory effects of berberine against morphine-induced locomotor sensitization and analgesic tolerance in mice. Neuroscience 142:953–961. doi:10.1016/j.neuroscience.2006.07.008

    Article  CAS  PubMed  Google Scholar 

  26. Moghaddam HK, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A (2013) Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. Metab Brain Dis. doi:10.1007/s11011-013-9411-5

    PubMed  Google Scholar 

  27. Choi S-W, Benzie IFF, Ma S-W, Strain JJ, Hannigan BM (2008) Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med 44:1217–1231. doi:10.1016/j.freeradbiomed.2007.12.005

    Article  CAS  PubMed  Google Scholar 

  28. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1–34. doi:10.1016/j.pharmthera.2008.05.005

    Article  CAS  PubMed  Google Scholar 

  29. Orie NN, Zidek W, Tepel M (1999) Reactive oxygen species in essential hypertension and non-insulin-dependent diabetes mellitus. Am J Hypertens 12:1169–1174. doi:10.1016/S0895-7061(99)00129-6

    Article  CAS  PubMed  Google Scholar 

  30. Hirao K et al (2010) Association of increased reactive oxygen species production with abdominal obesity in type 2 diabetes. Obes Res Clin Pract 4:e83–e90. doi:10.1016/j.orcp.2009.09.004

    Article  CAS  PubMed  Google Scholar 

  31. Steel JH et al (1994) Increased nitric oxide synthase immunoreactivity in rat dorsal root ganglia in a neuropathic pain model. Neurosci Lett 169:81–84. doi:10.1016/0304-3940(94)90361-1

    Article  CAS  PubMed  Google Scholar 

  32. Sepici-Dincel A, Açıkgöz Ş, Çevik C, Sengelen M, Yeşilada E (2007) Effects of in vivo antioxidant enzyme activities of myrtle oil in normoglycaemic and alloxan diabetic rabbits. J Ethnopharmacol 110:498–503. doi:10.1016/j.jep.2006.10.015

    Article  CAS  PubMed  Google Scholar 

  33. Baydas G, Nedzvetskii VS, Tuzcu M, Yasar A, Kirichenko SV (2003) Increase of glial fibrillary acidic protein and S-100B in hippocampus and cortex of diabetic rats: effects of vitamin E. Eur J Pharmacol 462:67–71. doi:10.1016/S0014-2999(03)01294-9

    Article  CAS  PubMed  Google Scholar 

  34. Kulkarni SK, Dhir A (2010) Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother Res: PTR 24:317–324. doi:10.1002/ptr.2968

    Article  CAS  PubMed  Google Scholar 

  35. Wang X et al (2005) Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract. Life Sci 77:3058–3067. doi:10.1016/j.lfs.2005.02.033

    Article  CAS  PubMed  Google Scholar 

  36. Zhou J-Y, Zhou S-W (2011) Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 82:184–189. doi:10.1016/j.fitote.2010.08.019

    Article  CAS  PubMed  Google Scholar 

  37. Yin J, Ye J, Jia W (2012) Effects and mechanisms of berberine in diabetes treatment. Acta Pharm Sin B 2:327–334. doi:10.1016/j.apsb.2012.06.003

    Article  CAS  Google Scholar 

  38. Siow YL, Sarna L, Karmin O (2011) Redox regulation in health and disease—therapeutic potential of berberine. Food Res Int 44:2409–2417. doi:10.1016/j.foodres.2010.12.038

    Article  CAS  Google Scholar 

  39. Tang L-Q, Wei W, Chen L-M, Liu S (2006) Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 108:109–115. doi:10.1016/j.jep.2006.04.019

    Article  CAS  PubMed  Google Scholar 

  40. Zhang Q et al (2011) Preventive effect of Coptis chinensis and berberine on intestinal injury in rats challenged with lipopolysaccharides. Food Chem Toxicol 49:61–69. doi:10.1016/j.fct.2010.09.032

    Article  CAS  PubMed  Google Scholar 

  41. Kalalian-Moghaddam H, Baluchnejadmojarad T, Roghani M, Goshadrou F, Ronaghi A (2013) Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur J Pharmacol 698:259–266. doi:10.1016/j.ejphar.2012.10.020

    Article  CAS  PubMed  Google Scholar 

  42. Jahanshahi M, Golalipour MJ, Afshar M (2009) The effect of Urtica dioica extract on the number of astrocytes in the dentate gyrus of diabetic rats. Folia Morphol (Warsz) 68:93–97

    CAS  Google Scholar 

  43. Pekny M, Wilhelmsson U, Bogestal YR, Pekna M (2007) The role of astrocytes and complement system in neural plasticity. Int Rev Neurobiol 82:95–111. doi:10.1016/S0074-7742(07)82005-8

    Article  CAS  PubMed  Google Scholar 

  44. O’Callaghan JP, Sriram K (2005) Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin Drug Saf 4:433–442. doi:10.1517/14740338.4.3.433

    Article  PubMed  Google Scholar 

  45. Fernandez-Fernandez S, Almeida A, Bolanos JP (2012) Antioxidant and bioenergetic coupling between neurons and astrocytes. Biochem J 443:3–11. doi:10.1042/BJ20111943

    Article  CAS  PubMed  Google Scholar 

  46. Dringen R, Gutterer JM, Hirrlinger J (2000) Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. Eur J Biochem / FEBS 267:4912–4916

    Article  CAS  Google Scholar 

  47. Yoo HJ et al (2008) Anti-inflammatory, anti-angiogenic and anti-nociceptive activities of Saururus chinensis extract. J Ethnopharmacol 120:282–286. doi:10.1016/j.jep.2008.08.016

    Article  PubMed  Google Scholar 

  48. Ingkaninan K, Phengpa P, Yuenyongsawad S, Khorana N (2006) Acetylcholinesterase inhibitors from Stephania venosa tuber. J Pharm Pharmacol 58:695–700. doi:10.1211/jpp.58.5.0015

    Article  CAS  PubMed  Google Scholar 

  49. Dhir A, Naidu PS, Kulkarni SK (2007) Neuroprotective effect of nimesulide, a preferential COX-2 inhibitor, against pentylenetetrazol (PTZ)-induced chemical kindling and associated biochemical parameters in mice. Seizure-Eur J Epilep 16:691–697. doi:10.1016/j.seizure.2007.05.016

    Article  Google Scholar 

  50. Lu DY, Tang CH, Chen YH, Wei IH (2010) Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia. J Cell Biochem 110:697–705. doi:10.1002/jcb.22580

    Article  CAS  PubMed  Google Scholar 

  51. Liu Q, Chen L, Hu L, Guo Y, Shen X (2010) Small molecules from natural sources, targeting signaling pathways in diabetes. Biochim Biophys Acta 1799:854–865. doi:10.1016/j.bbagrm.2010.06.004

    Article  CAS  PubMed  Google Scholar 

  52. Vannucci SJ, Maher F, Simpson IA (1997) Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 21:2–21

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Ms. Zahra Amanpour and Dr. Aziz Ronaghi for their kind support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hamid Kalalian Moghaddam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moghaddam, H.K., Baluchnejadmojarad, T., Roghani, M. et al. Berberine Ameliorate Oxidative Stress and Astrogliosis in the Hippocampus of STZ-Induced Diabetic Rats. Mol Neurobiol 49, 820–826 (2014). https://doi.org/10.1007/s12035-013-8559-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-013-8559-7

Keywords

Navigation